Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1983-04-07
1988-08-23
Wiseman, Thomas G.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
4351723, 435212, 435215, 435253, 435320, 536 27, 935 14, 935 29, 935 32, 935 70, 935 73, C12N 500, C12N 1500, C12N 948, C12N 972, C12N 120, C12N 100, C07H 1700
Patent
active
047660759
ABSTRACT:
Human tissue phasminogen activator (t-PA) is produced in useful quantities using recombinant DNA techniques. The invention disclosed thus enables the production of t-PA free of contaminants with which it is ordinarily associated in its native cellular environment. Methods, expression vehicles and various host cells useful in its production are also disclosed.
REFERENCES:
patent: 3904480 (1975-09-01), Hull et al.
patent: 4245051 (1981-01-01), Reich et al.
patent: 4259447 (1981-03-01), Hafeli
patent: 4314994 (1982-02-01), d'Hinterland et al.
patent: 4317882 (1982-03-01), Horiguchi et al.
patent: 4370417 (1983-01-01), Hung et al.
patent: 4505893 (1985-03-01), Mori et al.
Gene Expression, vol. 2, Lewin, B. (Ed.), pp. 148-153, 1974.
Ordahl, C. et al., Proc. Natl. Acad. Sci., vol. 77, No. 8, pp. 4519-4523, 1980.
Molecular Cloning (Maniatis, Fritsch & Sambrook, Eds.), Cold Spring Harbor Laboratory, pp. 224-228, 1982.
Heyneker, H. et al., Proc. of IVth Internat'l Symposium on Genetics of Industrial Microorganisms (Eds. Ikeda & Beppu), pp. 214-221, 1982.
Ratzkin, B. et al., Proc. Natl. Acad. Sci, vol. 78, No. 6, pp. 3313-3317, 1981.
Genetic Engineering Letter, vol. 2, No. 7, (Fishbeyn, G., Publisher), Sep. 10, 1982.
Biotechnology News, vol. 3, No. 5, Mar. 1, 1983.
Genetic Engineering News, p. 24, Mar. 1985.
Sargent, T. et al., Proc. Natl. Acad. Sci., vol. 78, No. 1, pp. 243-246, Jan. 1981.
Opdenakker, H. et al., Eur. J. Biochem., vol. 121, 269-274, 1982.
Ringold, G. et al., J. Mol. Appl. Genet., 1(3), 165-75, 1982; Chem. Abst. 96:175313p, 1982.
O'Hare et al., Proc. Natl. Acad. Sci., vol. 78(3), 1527-31, 1981.
Martial, J. et al., Science, vol. 205, 602-607, 1979.
Rijken, D. C. et al., J. of Biol. Chem, vol. 256(13), pp. 7035-7041 (1981).
Rijken, D. C. et al., Biochim Biophys. Acta., vol. 580, pp. 140-153 (1979).
Bollen, A., Biochem. Biophys. Res. Comm., vol. 97(1), pp. 207-215, 1980.
Edlund, T. et al., Proc. Natl. Acad. Sci., vol. 80, pp. 349-352 (1983).
Pennica, D. et al., Nature, vol. 301, pp. 214-221 (1983).
Hoylaerts et al., J.B.C. 257, No. 6, 2912-2919 (1982).
Weimar et al., The Lancet 2, 1018-1020 (Nov. 7, 1981).
Widman et al., Nature 272, No. 5648, 549-550 (Mar. 2, 1978).
Allen, Cell Biol. Int. Rep., 4(9), 803 (1980).
Chemical Abstracts, vol. 93, 183281e, p. 396 (1980).
Angles-Cano et al., C. R. Acad. Sc., Paris, 289, p. 485 (1979).
Chemical Abstracts, vol. 92, 36746m (1980).
Aoki, J. Biochem. 75, p. 731 (1974).
Astrup et al., Arch. Biochem. Biophys. 40, 346-351 (1952).
Barlow et al., Proc. Serono Symp. 9, pp. 75-80 (1977).
Chem. Abstracts 89, No. 7, 57188j., p. 360 (1978).
Binder et al., J. of Biol. Chem. 254, p. 1998 (1979).
Goeddel David V.
Kohr William J.
Pennica Diane
Vehar Gordon A.
Genentech Inc.
Huleatt Jayme A.
Wiseman Thomas G.
LandOfFree
Human tissue plasminogen activator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human tissue plasminogen activator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human tissue plasminogen activator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-835669